Send us a text

When is it safe to giving HRT in women who are being treated or have previously been diagnosed with breast cancer?

Will the use of vaginal oestrogens affect breast cancer outcomes?

What is the trade off on quality of life when symptoms of the menopause aren't managed?

Did you know that roughly 1 in 4 women stop their hormone therapy for breast cancer due to menopausal side effects!!

Who better to answer these questions and more than Dr Rebecca Bowen, Consultant Oncologist in Royal University Hospitals Bath who specialises in the treatment of breast and gynaecological cancers and heads up the specialist cancer and menopause unit.

Send us a text

Sexual health in cancer is a topic we need to talk more about.

So many patients feel unable to discuss their sexual health and also clinical teams don’t also mange to bring the topic up.

A cancer diagnosis can affect self image and confidence.

We talk to Lorraine Grover who is a sexual health specialist nurse about how we can break down some of these barriers.

Erectile dysfunction and much more discussed.

You may never look at a Calypo ice lolly the same again !!

This episode does contain some adult themes.

Send us a text

We return to Part 2 of our walk through metastatic bowel cancer with the excellent Professor Naureen Starling.

We look at RAS, BRAF and future directions for treatment of metastatic bowel cancer.

Can ctDNA have a role in metastatic bowel cancer?

What role may HER2 have to play going forward?

What is exciting on the horizon in mCRC?

Enjoy!!

Send us a text

Send us a text

Join us as we return for Part 2 with the superb Dr Alison Berner.

It’s Transgender Awareness Week and we discuss resources to support patients and clinicians.

We discuss OUTpatients and UCATS - UK cancer and transition service.

Send us a text

As we approach transgender awareness week we discuss cancer care in the transgender community with the exceptional Dr Alison Berner.

1 in 40 people aged under 30 identify as transgender in recent census.

How we give support needed and signpost patients can have a huge influence on their experience of care.

Alison has done so much work in this area.

We learned a lot in this episode and we hope you enjoy!

https://outpatients.org.uk/

https://www.wearetransplus.co.uk/uk-cancer-and-transition-service/

Send us a text

We return to discuss stereotactic radiotherapy (SABR) in prostate cancer with the superb Dr Alison Tree from The Royal Marsden Hospital.

We discuss the findings of the TRAP study which extended time to next treatment by 6 months when SABR was used for sites of growing disease.

Do we always need to change systemic therapy when only one or two sites of metastatic disease is growing??

Send us a text

We are back for part 2 to finish our journey through the Gut Microbiome with the excellent Professor Monty Pal !!

Few areas of cancer treatment have generated as much interest as the Gut Microbiome in recent years.

We discuss work done by Monty's team on CBM588 on immunotherapy in kidney cancer.

CBM 588 is a live bacterial product that is available in health shops in Japan where it is used to promote a healthy gut.

Monty's team found incredible results where it improved response rates for immunotherapy containing treatment and significantly improved time to tumour progression.

Plans are now afoot to trial this in a much larger phase 3 trial which could readout some exciting results!

We discuss;

- Should we run patient poo through an AI algorithm to see what gut microbiome changes are needed

- Can we engineer gut bacteria to make more of useful proteins in our gut

- Can we get more biotech companies to engage in this space to help move it forward at more pace

Of course Monty knocks it out of the park so he gets a Simply Oncology wish!!

Amazing to hear Professor Monty Pal share his thoughts on this exciting area of medicine.